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The choroid plexuses (ChP) are highly vascularized tissues suspended from each of
the cerebral ventricles. Their main function is to secret cerebrospinal fluid (CSF) that
fills the ventricles and the subarachnoid spaces, forming a crucial system for the
development and maintenance of the CNS. However, despite the essential role of the
ChP–CSF system to regulate the CNS in a global manner, it still remains one of the
most understudied areas in neurobiology. Here we define by immunohistochemistry
the expression of different proteins involved in the maturation and functionality of the
ChP from the late embryological period to maturity. We found an opposite gradient of
expression between aquaporin 1 (AQP1) and glucose transporter 1 (Glut 1) that define
functional maturation in the ChP periphery, and proliferating cell nuclear antigen (PCNA)
and calbindin (CB), present in the ChP root zone with proliferative activity. We conclude
that the maturation of the ChP matures from distal to proximal, starting in the areas
nearest to the cortex, expressing in the distal, mature areas AQP1 and Glut1 (related to
ChP functionality to support cortex development), and in the proximal immature areas
(ChP root) CB and PCNA related to progenitor activity and proliferation.
Keywords: aquaporin-1, Glut1, calbindin, PCNA, choroid plexus development
INTRODUCTION
The choroid plexuses (ChP) are highly vascularized tissues suspended from each of the
cerebral ventricles. They comprise a central stroma with numerous blood vessels covered
by a single layer of specialized epithelial cells (the choroid epithelium) resting on a thick
basement membrane (Johanson et al., 2008; González-Marrero et al., 2012, 2015). These
specialized organs have two major functions: to act as a diffusion barrier between the blood
and the cerebrospinal fluid (CSF; the site of the blood–CSF barrier) allowing or inhibiting
the passing of proteins as a growth factors, and to secrete CSF that fills the ventricles
and the subarachnoid spaces. The ChP is considered a crucial system for the development
and maintenance of the CNS (Davson and Segal, 1995; Johanson, 1995; Lun et al., 2015).
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However, during brain development these functions might
be quite different from those in the adult brain, given that
both, the size of the ChP and the size of the CSF-filled
brain ventricles in relation to brain size, are much larger in
development than in the adult, and that in the early stages
of brain development no vessels are present within the brain
parenchyma, the ChPmay be of crucial importance for supplying
developmentally essential materials from the blood to the brain at
that time point (Klosovskii, 1963; Ek et al., 2003; Johansson et al.,
2005).
Prior to ChP formation, a primitive ventricular system is
first formed when the neural tube closes and amniotic fluid
is trapped within the central canal. This closure is associated
with a subsequent rise of intraventricular fluid pressure and
increase in CSF protein concentration, and coincides with a
start of rapid brain enlargement. Desmond (1985) and Desmond
and Jacobson (1977) suggested that the ventricular fluid might
provide an essential pressure force for normal brain expansion
and morphogenesis, with the ChP taking over this function.
The choroid plexus epithelium (ChPE) forms as an
invagination of the neuroepithelium which differentiates
into more specialized epithelial cells following four stages.
Initially in stage I, these cells form a pseudostratified epithelium,
in stage II, they form a simple high columnar epithelium, in stage
III the epithelial cells flatten and widen forming a squamous
epithelium presenting apical or centrally positioned nuclei and
increased levels of glycogen content. In most species this stage
can be followed by stage IV, which is characterized by lower
glycogen content and basally positioned nuclei (Dziegielewska
et al., 2001; Johansson et al., 2005; Lun et al., 2015).
However, despite the essential role of the ChP–CSF system to
regulate the CNS in a global manner, it still remains one of the
most understudied areas in neurobiology (Lun et al., 2015).
In order to understand the development of the human
ChP–CSF system, we examined the expression of different key
proteins involved in the functionality and maturation of ChP
during the fetal cortex development.
1. Aquaporin 1 (AQP1) is a water channel protein that makes a
substantial contribution to CSF production and is expressed
in early stages of brain development (Johansson et al., 2005;
Gömöri et al., 2006). This expression follows a temporo-
spatial progression during fetal life, starting in ChPE of the
fourth ventricle, then in the lateral and finally in the third
ventricle (3V), following the same order as the regional
histology of ChPE in developing fetal ventricles (Johansson
et al., 2005), being a reliable marker of the functionality of the
ChP.
2. Glucose transporter 1 (Glut 1), is a uniporter protein that
transports glucose from the extracellular medium into cells
(Bolz et al., 1996; Kapoor et al., 2016). Given the importance
of the presence of glycogen for ChPE cell maturation, we
propose Glut1 as good marker for understanding the ChP
development.
3. Calcium-binding proteinD-28K (Calbindin, CB), is amember
of the large family of intracellular calcium-binding proteins
related to calmodulin and troponin-C. CB plays biological
roles in calcium regulation (transport, uptake, calcification
of bone and teeth) and calcium related signaling in neurons,
and transiently in embryological development. CB stains a
regionalized area in human brain development, defining the
neuroepithelium of the cortical hem, the medial boundary
of the cortex with the ChP, at 6 gestational weeks (GW),
and is therefore a reliable marker for the human ChP in
the early development. (Meyer, 2010; González-Gómez and
Meyer, 2014).
4. Proliferating cell nuclear antigen (PCNA) is a cofactor
of DNA polymerases that encircles DNA and orchestrates
several of the replication functions by recruiting crucial
mitotic players (Moldovan et al., 2007). It is only expressed
in proliferating cells, and thus allows us to understand the
mitotic pattern of the developing ChPE.
Taking into account the ultrastructural studies that have
been performed on the ChPs from all four ventricles, where
they all undergo identical developmental stages (el-Gammal,
1981, 1983; Ek et al., 2003) and that, this work is focused
in the cortical brain development, the aim of this work is
to define immunohistochemically the expression of different
proteins involved in the maturation and possible functionality of
the telencephalic ChPs from the late embryological period to the
end of the ChP development.
MATERIALS AND METHODS
Fourteen late embryonic and fetal brains at 7, 8, 9, 10(3),
13, 15(2), 16(2), 20, 21 and 25 GW, one newborn infant and
three adult men brains (59, 63 and 73 years old respectively)
were used in this work. The brains were from the collection
of the Department of Anatomy at the University of La
Laguna. Parents had given written informed consent. The ethical
committee of the University of La Laguna and the University
Hospital of the Canary Islands approved and supervised the
study.
The brains were processed using the following standardized
protocol: fixation in formaldehyde, post fixation in Bouin or
paraformaldehyde for 24 h, dehydration and paraffin embedding.
The brains were then cut in four (A, B, C and D) coronal series
of 10 microns thick sections. The A series were stained with
hematoxylin-eosin (H-E) and the B, C and D series were used
for immunohistochemistry.
Immunocytochemistry and
Immunofluorescence
Tissue sections were deparaffinized in xylene, hydrated through
descending ethanol and washed in Tris-buffer saline (TBS
0.05 M; pH 7.6). For immunocytochemistry, sections were
incubated in the primary antibodies; rabbit anti-AQP1 (Sigma-
Aldrich) at 1:1000, rabbit anti-CB 38a (Swant) at 1:7000, mouse
anti-PCNA (Abcam) at 1:200 and mouse anti-Glut1(Abcam)
at 1:250 overnight in a humid chamber and Goat anti-
rabbit and mouse IgG conjugate antibodies (Invitrogen)
were used as secondary antibodies. In light microscopy,
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FIGURE 1 | Paraffin coronal section of human brain embryo-fetus at seven gestational weeks (GW) showing LV and ChP marked with anti-AQP1,
anti-PCNA and anti-CB. (A) Panoramic view showing the AQP1 immunoreaction, bar = 600 µm; (B,C) detailed magnification of the distal ChP in (A), where the
expression of AQP1 is localized in the apical cell pole of the ChP epithelium. (D) PCNA immunoreaction. (E) anti-CB expression, bar = 40 µm in (C) and 80 µm in
(B,D,E; Arrowheads indicate the expression of proteins). AQP1, aquaporin 1; CB, calbindin; PCNA, proliferating cell nuclear antigen; LV, lateral ventricle; FM, foramen
of monro; Tha, thalamus; ChP, choroid plexus.
the ‘‘DAKO’’ Strept ABC complex/HRP Duet, Mouse/Rabbit
procedure was used and the peroxidase reaction product
visualized with diaminobenzidine intensified with nickel. For
immunofluorescence, sections were incubated with the following
secondary antibodies; Cyanine 3 (Cy3; red) goat anti-rabbit
IgG (Invitrogen) and alexa-fluor 488 (green; Invitrogen). After
washes, samples were mounted in Vectashield Medium (Vector
Laboratories Inc.) for viewing with a confocal microscope (FV
1000 Olympus).
RESULTS
CB and PCNA were detected in the cytosol and in the
nucleus, respectively, at 7 GW (Figure 1) in the entire
ChP anlage, but at 8 and 10 GW this expression was lost
from distal to proximal (Figures 2B,C, 3D), remaining
only in the mitotically active zones of the ChP stalk
(Figures 2D, 3E). At 20 GW this expression was no longer
observed.
AQP1 expression was first observed in the ChP at 7 GW
(Figures 1B,C). This expression begins in the distal areas, away
from the choroidal stem, forming small immunoreactive foci.
At 7 and 8 GW, the ChP was mainly a pseudostratified
epithelium and AQP1 was expressed only in the apical
pole of the ChPE cells in contact with the ventricle. At
10 GW, the size of the ChP was greatly increased, filling
most of the ventricular cavities. Moreover, the presence
of connective tissue and a few choroidal folds were also
observed. AQP1 expression was detected at the apical
pole of the ChPE cells (Figures 3A,B) but there was no
immunoreactivity in the choroidal stem and adjacent areas,
which were, in turn, positive for the mitotic markers (PCNA;
Figures 3C,E).
At 21 GW (Figures 4A–C), AQP1 expression was not
only detected in the apical membrane of the ChPE cells,
but also in their basolateral membrane even reaching the
basal pole. However, at 25 GW, when choroidal folds had
increased in numbers, AQP1 expression was concentrated
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FIGURE 2 | Paraffin coronal section of human brain fetus at 8 GW showing LV and ChP marked with anti-CB and anti-PCNA. (A) Panoramic view
showing the anti-CB immunoreaction in epithelial cells of the ChP, bar = 600 µm; (B) detailed magnification of area frame in (A), bar = 80 µm; (C,D) anti-PCNA
expression in the distal and proximal areas of the ChP, bar = 80 µm in (C) and 60 µm in (D; Arrowheads indicate the expression of CB and PCNA, and arrows
indicate where its expression is lost). CB, calbindin; PCNA, proliferating cell nuclear antigen; LV, lateral ventricle; Tha, thalamus; ChP, choroid plexus.
again limited at the apical pole (Figures 4D–F). In the
adult, we found that the expression of AQP1 was not only
in the apical pole but also in the supranuclear domain.
(Figures 4G–I).
Glut1 was detected for first time at 9 GW in the basolateral
membrane of the distal area of ChP (Figures 3F,G), presenting no
changes during the entire gestational progress in its intracellular
location.
We thus found that the expression of AQP1 and CB
follow an opposite gradient, with AQP1 following a distal-
proximal expression in ChPE cells that were negative for PCNA
(Figures 5A,B); CB was expressed throughout the ChP anlage at
7 GW, and was thereafter restricted to the proximal ChP root,
mainly in proliferating cells (Figures 2A, 4A,C,D).
DISCUSSION
At present, only two reports have studied AQP1 expression in
human brain development. Johansson et al. (2005) examined
fetuses from 5.5 to 23 GW, whereas Gömöri et al. (2006) studied
fetuses from 14 to 40 GW. We detect first expression of AQP1
in ChP at 7 GW, being located only in the apical pole of ChPE
in the beginning of the stage II (Table 1). Our findings basically
concur with Johansson et al. (2005), who describe that towards
the end of the embryonic period (CRL: 28 mm) at 8 GW, the
majority of the ChP cells show positive AQP1 staining of the
apical cell membrane. However, we detected AQP1 even earlier,
at 7GW, in small foci of positive ChE cells, at the distal end
of the ChP, but not in the mitotically active choroid stem.
TABLE 1 | Correlative table of the expression (∗) or not expression (−) of
the proliferating cell nuclear antigen (PCNA), calbindin (CB), aquaporin 1
(AQP1) and glucose transporter 1 (Glut 1) in the different stages of the
choroid plexuses (ChP) development.
Marker Stage I Stage II Stage III Stage IV
PCNA ∗ − − −
CB ∗ ∗ − −
AQP1 − ∗ ∗ ∗
Glut 1 − − ∗ ∗
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FIGURE 3 | Paraffin coronal section of human brain fetus at 10 GW showing LV and ChP, marked with anti-AQP1, anti-PCNA and Glut1. (A) Panoramic
view showing the anti-AQP1 bar = 800 µm; (B) detailed magnification of area frame in (A), asterisk indicates the expression of AQP1 in the apical pole of ChPE,
bar = 80 µm; (C) undetectable AQP1 immunoreaction of the epithelial cells of the ChP root, bar = 80 µm; (D) panoramic view showing the anti-CB immunoreaction
that is lost in the distal choroid plexus epithelium (ChPE) and remains in the stalk, bar = 200 µm; (E) detailed of ChP root marked with anti-PCNA, bar = 30 µm.
(F) Panoramic view showing the anti-Glut1 only expressed in the distal areas of the ChP, bar = 200 µm and (G) detailed magnification of area frame in (F) showing
the expression of Glut1 located in the basolateral membrane of the ChPE, bar = 30 µm (Arrowheads indicate the expression of CB, PCNA, Glut1 and AQP1, and
arrows indicate where its expression is lost or have had no place). AQP1, aquaporin 1; CB, calbindin; PCNA, proliferating cell nuclear antigen; Glut1, Glucose
transporter 1; LV, lateral ventricle; FM, foramen of monro; Tha, thalamus; 3V, third ventricle; GE, ganglionic eminence; Hta, hypothalamus.
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FIGURE 4 | Paraffin coronal section of human brain fetus at 21 (A–C) and 25 (D–F) GW, and a 63 year old human brain (G–I) showing LV and ChPE
marked with anti-AQP1 (arrow). (A) Panoramic view of ChP showing anti-AQP1, bar = 200 µm at 21 GW; (B) magnification of area frame in (A), bar = 60 µm;
(C) detailed magnification at 21 GW showing detectable AQP1 immunoreaction in the apical, lateral and basal domain of the ChP epithelial, bar = 10 µm;
(D) panoramic view showing the anti-AQP1 in ChP at 25 GW, bar = 200 µm; (E,F) ChP magnification showing anti-AQP1 mainly in the apical pole of the epithelial
cells, bar = 60 and 10 µm respectively; (G–I) show anti-AQP1 mainly in the apical pole of the ChP epithelial cells of the 63 year old man, bar = 200, 60 and 10 µm
respectively: (arrows indicate the expression of AQP1 in the apical pole of the ChP epithelium, arrowheads indicate its expression in the basolateral domain of the
epithelial cells and the asterisks indicate the folds of the ChP). AQP1, aquaporin 1; LV, lateral ventricle; St, stroma.
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FIGURE 5 | Drawing and Paraffin coronal section of the brain of a human fetus at 10 GW. (A) ChP (frame of C) marked with anti-AQP1 and anti-PCNA, bar
100 = µm; (B) ChP (frame of C) marked with anti-CB and anti-PCNA, asterisk indicate a frame magnification of the root of the ChP, bar 100 µm; (C) panoramic view
showing of the ChP marked with anti-AQP1, bar = 100 µm; (D) drawing of AQP1 and GLUT1 expression at latero-distal part of the ChP and neuroepithelium of the
ventricular zone (VZ) of the LV; (E) panoramic coronal view showing the whole LV and ChP, bar = 800 µm; (F) drawing of PCNA and CB expression at ChP root
(proximal or medial part of ChP; Arrowheads indicate the expression of PCNA, AQP1 and CB and arrows indicate where its expression is not present). AQP1,
aquaporin 1; CB, calbindin; PCNA, proliferating cell nuclear antigen; GLUT1, Glucose transporter 1; LV, lateral ventricle; FM, foramen of monro; Tha, thalamus; 3V,
third ventricle; GE ganglionic eminence; Hta, hypothalamus.
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A few weeks later, at 10 GW, we found immunostaining in
the entire ChP except in the stem. We thus detect a temporo-
spatial pattern in AQP1 expression that starts in small foci
distally and progresses proximally toward the ChP stem. This
pattern parallels histological differentiation of the ChP which
follows the same distal-to -proximal gradient (el-Gammal, 1981,
1983; Zheng and Chodobski, 2005; Lun et al., 2015). The cells
at the stem or root of the ChP are less mature and remain
mitotically active for a longer period compared to the more
distal ChP folds. Growth of the ChP is thus initiated at the
root, where most mitotic figures are found, and where the cells
show a pseudostratified appearance until later in development
(Knudsen, 1964; Tennyson and Pappas, 1964; Ek et al., 2003;
Zheng and Chodobski, 2005).
Glut 1 follows the same pattern of expression than AQP1 but
delayed in time. We first observed the Glut 1 expression at 9 GW
in the distal areas of the ChP progressing to the proximal areas,
indicating different stages of the maturation and functionality of
the ChP and corresponding with the stage III of the development
of the ChP (Table 1). Exactly the opposite happened with CB
and PCNA: where these proteins were expressed, there was
no expression of AQP1 and Glut1or was scarcely expressed
(Figures 5C–F), suggesting they are markers for ChP progenitor
cells. Since AQP1 and Glut1 are involved in the maturation and
production of the CSF, our findings suggest that the ChP starts
to be active from very early stages of brain development in the
distal areas of the ChP, close and almost adjacent to the cortex,
as a possible source of growth factors for cortex development
because of the its low vascularization in early fetal development
(Klosovskii, 1963; Ek et al., 2003; Johansson et al., 2005). At the
same time the proximal root of the ChP still keeps its progenitor
activity which allows the ChP to keep growing in order to be able
to adapt the ChP size to the growth of the lateral ventricle (LVs)
in telencephalic development.
From the late embryonic age to adulthood we found dynamic
changes in AQP1 expression. Initially it appeared only in the
apical cell membranes, at midgestation also in the basolateral
membranes and, after 25 GW, expression was exclusively in
the apical membrane, as also described by Johansson et al.
(2005) and Gömöri et al. (2006). In the adulthood, we also
found a supranuclear expression of the AQP1, recently described
for our group (Castañeyra-Ruiz et al., 2016). Therefore the
polarization of AQP1 expression undergoes dynamic changes
along gestation, possibly related with CSF production that might
provide different ventricular pressure forces to support brain
expansion at distinct moments of corticogenesis.
AQP1 expression appears for the first time in the ChP at 7
GW following a distal to proximal pattern of expression, and then
changes dynamically during development, adjusting ventricular
size and CSF production according to the requirements of the
expanding brain. Glut 1 appears for the first time at 9 GW,
following the same gradient of expression than AQP1 although
delayed.
CB and PCNA follow a decreasing pattern of expression from
distal to proximal indicating the ongoing progenitor activity
of the ChP stalk during the first half of gestation and mainly
related to the stage I of the ChP development (Table 1). In
conclusion, the telencephalic ChP differentiates from distal to
proximal, starting to mature in the areas nearest to the cortex,
and expressing proteins such as AQP1 and Glut1, while still
expressing CB and PCNA in the root, indicating immaturity and
proliferation.
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